TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT04839705: Post-Approval Study - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Sponsor: Microvention-Terumo, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 200 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$6,972,000

Rescue Site Savings

+$4,614,800

Unlock Full NCT04839705 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04839705 Rescue Dossier →